Loading clinical trials...
Loading clinical trials...
Modulation of Morbidity and Disease Progression in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Patients With Obstructive Sleep Apnea (OSA) by CPAP
Conditions
Interventions
Continuous Positive Airway Pressure
Patient Observation
+1 more
Locations
2
United States
Huntsman Cancer Institute/University of Utah
Salt Lake City, Utah, United States
Veterans Administration Medical Center
Salt Lake City, Utah, United States
Start Date
May 15, 2019
Primary Completion Date
July 28, 2023
Completion Date
July 28, 2023
Last Updated
January 8, 2024
NCT07357727
NCT06976918
NCT06343805
NCT06456346
NCT05123365
NCT04645199
Lead Sponsor
University of Utah
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions